Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00855439 · ClinicalTrials.gov registry record · NA
Evaluation of Exenatide in Patients With Diabetic Neuropathy
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT00855439 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 46 participants.
The verdict
NCT00855439, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study will look at whether or not the medication exenatide improves signs and symptoms of diabetic peripheral neuropathy in people with type 2 diabetes and mild to moderate diabetic peripheral neuropathy.
Interventions
- DRUG Exenatide
- DRUG Glargine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-06 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00855439
The ClinicalTrials.gov registry entry for NCT00855439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exenatide is the first listed.
NCT00855439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00855439 about?
NCT00855439 is a clinical study titled "Evaluation of Exenatide in Patients With Diabetic Neuropathy". This study will look at whether or not the medication exenatide improves signs and symptoms of diabetic peripheral neuropathy in people with type 2 diabetes and mild to moderate diabetic peripheral neuropathy.
What is the current status of trial NCT00855439?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2008-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00855439?
The interventions under investigation include: Exenatide (DRUG), Glargine (DRUG).
Who is sponsoring clinical trial NCT00855439?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.